Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

UNLABELLED This study assessed the clinical performance of a combined PET/CT system using (18)F-FDG in oncologic patients. METHODS (18)F-FDG PET/CT was used to evaluate 204 patients with 586 suspicious lesions. All patients had available follow-up data, enabling assessment of the clinical significance of hybrid PET/CT findings. Differences in interpretation between PET, CT, and fused PET/CT data were prospectively documented for detection, localization, and characterization of each evaluated site. The additional value of PET/CT for data interpretation over that of separate PET and CT was classified into several criteria, including change in lesion characterization to either definitely benign or definitely malignant, precise anatomic localization of malignant (18)F-FDG uptake, and retrospective lesion detection on PET and CT. The clinical impact of information provided by PET/CT on patient management was assessed on the basis of follow-up data concerning further diagnostic or therapeutic approach. Analysis of data was performed for the whole study population, for different types of cancer, and for different anatomic sites. RESULTS PET/CT provided additional information over the separate interpretation of PET and CT in 99 patients (49%) with 178 sites (30%). PET/CT improved characterization of equivocal lesions as definitely benign in 10% of sites and as definitely malignant in 5% of sites. It precisely defined the anatomic location of malignant (18)F-FDG uptake in 6%, and it led to retrospective lesion detection on PET or CT in 8%. The results of PET/CT had an impact on the management of 28 patients (14%). Hybrid PET/CT data obviated the need for further evaluation in 5 patients, guided further diagnostic procedures in 7 patients, and assisted in planning therapy for 16 patients. CONCLUSION Hybrid PET/CT improves the diagnostic interpretation of (18)F-FDG PET and CT in cancer patients and has an impact on both diagnostic and therapeutic aspects of patient management.

[1]  C. Meltzer,et al.  Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. , 2002, Gynecologic Oncology.

[2]  C. Meltzer,et al.  Physiologic Uterine Uptake of FDG During Menstruation Demonstrated with Serial Combined Positron Emission Tomography and Computed Tomography , 2002, Clinical nuclear medicine.

[3]  K D Hopper,et al.  Body CT and oncologic imaging. , 2000, Radiology.

[4]  J. Dutcher,et al.  Overview by an oncologist: what are the imaging needs of the oncologist and oncological surgeon? , 1997, Seminars in nuclear medicine.

[5]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  R. Wahl,et al.  PET Scanning and Measuring the Impact of Treatment , 2002, Cancer journal.

[7]  R. Hustinx,et al.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose , 1996, European Journal of Nuclear Medicine.

[8]  Cyrill Burger,et al.  Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion -- report of six cases. , 2002, Radiology.

[9]  J Kotzerke,et al.  Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest. , 1999, Acta oncologica.

[10]  Z. Keidar,et al.  The fusion of anatomic and physiologic imaging in the management of patients with cancer. , 2001, Seminars in nuclear medicine.

[11]  M P Sandler,et al.  Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  C. Meltzer,et al.  Image Analysis in Patients with Cancer Studied with a Combined PET and CT Scanner , 2000, Clinical nuclear medicine.

[13]  W. Scott.  Positron emission tomography (PET) and combined imaging modalities for staging lung cancer. , 2002, The Surgical clinics of North America.

[14]  R. Coleman,et al.  Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. , 2002, The Annals of thoracic surgery.

[15]  R. Wahl,et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.

[16]  M D Blaufox,et al.  PET imaging in oncology. , 2000, Seminars in nuclear medicine.

[17]  Gerald J. Kutcher,et al.  The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer , 2000 .

[18]  S. Cherry,et al.  Combining anatomy and function: the path to true image fusion , 2001, European Radiology.

[19]  F. Maes,et al.  FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? , 1998, European Journal of Nuclear Medicine.

[20]  D W. Townsend,et al.  Combined PET/CT Imaging in Oncology. Impact on Patient Management. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[21]  Ora Israel,et al.  Combined functional and structural evaluation of cancer patients with a hybrid camera-based PET/CT system using (18)F-FDG. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  P. Shreve.  Adding structure to function. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  J. Correia,et al.  Registration of nuclear medicine images. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  C. Meltzer,et al.  Superphysiologic FDG Uptake in the Non-Paralyzed Vocal Cord. Resolution of a False-Positive PET Result with Combined PET-CT Imaging. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[25]  R. Wahl,et al.  "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  L. Thurfjell,et al.  Image registration: an essential tool for nuclear medicine , 2002, European Journal of Nuclear Medicine and Molecular Imaging.